Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.

about

Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.

Item

http://www.wikidata.org/entity/Q40211670

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacokinetics of Levofloxac ...... sistant Tuberculosis Patients.

@en

type

Item

label

Pharmacokinetics of Levofloxac ...... sistant Tuberculosis Patients.

@en

prefLabel

Pharmacokinetics of Levofloxac ...... sistant Tuberculosis Patients.

@en

P1476

Pharmacokinetics of Levofloxac ...... sistant Tuberculosis Patients.

@en

P2093

Alena Skrahina

http://www.w3.org/2001/XMLSchema#string

Jan-Willem C Alffenaar

http://www.w3.org/2001/XMLSchema#string

Jos G W Kosterink

http://www.w3.org/2001/XMLSchema#string

Kai van Hateren

http://www.w3.org/2001/XMLSchema#string

Susan van den Hof

http://www.w3.org/2001/XMLSchema#string

Tatiana Seuruk

http://www.w3.org/2001/XMLSchema#string

Tjip S van der Werf

http://www.w3.org/2001/XMLSchema#string

Tridia van der Laan

http://www.w3.org/2001/XMLSchema#string

P2860

Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.

Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions.

Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients

Comparison of side effects of levofloxacin versus other fluoroquinolones.

Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Clinical role of protein binding of quinolones.

P31

scholarly article

P356

10.1128/AAC.00343-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dick van Soolingen

Natasha Van't Boveneind-Vrubleuskaya

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28507117

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5527618

http://www.w3.org/2001/XMLSchema#string